Two Asian pharmas hold key for global supply of Oxford vaccine

Two Asian pharmas hold key for global supply of Oxford vaccine

Serum Institute of India CEO Adar Poonawalla. Photo: Abhijit Bhatlekar/Mint

Two Asian pharmaceutical companies are poised to become key players in the global fight against the new coronavirus pandemic after they were tapped to help mass-produce a promising new vaccine for the disease, which has already killed 650,000 worldwide and infected over 16 million.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter